Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Sep 15, 2022; 14(9): 1758-1770
Published online Sep 15, 2022. doi: 10.4251/wjgo.v14.i9.1758
Published online Sep 15, 2022. doi: 10.4251/wjgo.v14.i9.1758
Figure 3 The overall survival and progression-free survival of two groups.
A: The cumulative overall survival of the endoscopic debulking resection (EdR) + chemoradiotherapy (CRT) and EdR groups; B: The cumulative progression-free survival of the EdR + CRT and EdR groups. CRT: Chemoradiotherapy; EdR: Endoscopic debulking resection; OS: Overall survival.
- Citation: Ren LH, Zhu Y, Chen R, Shrestha Sachin M, Lu Q, Xie WH, Lu T, Wei XY, Shi RH. Endoscopic debulking resection with additive chemoradiotherapy: Optimal management of advanced inoperable esophageal squamous cell carcinoma. World J Gastrointest Oncol 2022; 14(9): 1758-1770
- URL: https://www.wjgnet.com/1948-5204/full/v14/i9/1758.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i9.1758